controversy about whether long-acting beta-agonists (salmeterol, etc) should be stopped once asthma is controlled

You'll hear new controversy about whether long-acting beta-agonists (salmeterol, etc) should be stopped once asthma is controlled.

Many patients end up on a combo corticosteroid and long-acting beta-agonist inhaler (Advair, etc) when an inhaled steroid alone is not enough for persistent asthma.

But these combo inhalers have a black box warning to stop them as soon as possible once asthma is controlled due to safety concerns.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote